ProfileGDS4718 / 204619_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 31% 27% 56% 19% 44% 41% 69% 24% 45% 36% 37% 38% 48% 62% 50% 47% 38% 75% 34% 83% 27% 36% 32% 42% 36% 68% 42% 69% 21% 31% 35% 75% 41% 27% 80% 74% 26% 52% 24% 73% 43% 54% 91% 75% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.6050931
GSM549102patient 115, normal, homogenized [OPG study]4.4370127
GSM549104patient 119, normal, homogenized [OPG study]5.8868356
GSM549108patient 138, normal, homogenized [OPG study]4.1387319
GSM549119patient 077, normal, homogenized [OPG study]5.2173244
GSM549133patient 032, cancer, homogenized [OPG study]5.0045241
GSM549139patient 042, cancer, homogenized [OPG study]6.8037269
GSM549099patient 107, normal, homogenized [OPG study]4.3005924
GSM549109patient 139, normal, homogenized [OPG study]5.293145
GSM549110patient 046, normal, homogenized [OPG study]4.8128936
GSM549114patient 063, normal, homogenized [OPG study]4.7999937
GSM549122patient 082, normal, homogenized [OPG study]4.9147938
GSM549134patient 033, cancer, homogenized [OPG study]5.3598548
GSM549136patient 036, cancer, homogenized [OPG study]6.2729462
GSM549140patient 044, cancer, homogenized [OPG study]5.4898950
GSM549111patient 047, normal, homogenized [OPG study]5.3175947
GSM549113patient 057, normal, homogenized [OPG study]4.8221638
GSM549132patient 031, cancer, homogenized [OPG study]7.3237975
GSM549137patient 038, cancer, homogenized [OPG study]4.6783434
GSM549142patient 047, cancer, homogenized [OPG study]7.8602983
GSM549100patient 110, normal, homogenized [OPG study]4.4452827
GSM549107patient 135, normal, homogenized [OPG study]4.757536
GSM549115patient 068, normal, homogenized [OPG study]4.5680132
GSM549116patient 072, normal, homogenized [OPG study]5.0462842
GSM549120patient 078, normal, homogenized [OPG study]4.7879336
GSM549131patient 030, cancer, homogenized [OPG study]6.7479668
GSM549118patient 074, normal, homogenized [OPG study]5.0729242
GSM549129patient 027, cancer, homogenized [OPG study]6.8342569
GSM549123patient 088, normal, homogenized [OPG study]4.1866321
GSM549124patient 006, cancer, homogenized [OPG study]4.6393831
GSM549126patient 015, cancer, homogenized [OPG study]4.7362335
GSM549128patient 025, cancer, homogenized [OPG study]7.3648875
GSM549103patient 117, normal, homogenized [OPG study]5.103441
GSM549117patient 073, normal, homogenized [OPG study]4.3860527
GSM549138patient 041, cancer, homogenized [OPG study]7.8684980
GSM549141patient 045, cancer, homogenized [OPG study]7.3731274
GSM549130patient 028, cancer, homogenized [OPG study]4.3908226
GSM549101patient 111, normal, homogenized [OPG study]5.6567752
GSM549105patient 128, normal, homogenized [OPG study]4.3122724
GSM549106patient 134, normal, homogenized [OPG study]7.2795173
GSM549112patient 048, normal, homogenized [OPG study]5.1166843
GSM549125patient 011, cancer, homogenized [OPG study]5.7363254
GSM549127patient 024, cancer, homogenized [OPG study]9.3495791
GSM549135patient 035, cancer, homogenized [OPG study]7.4390275